TYPE OF BUSINESS
Nova Laboratories Ltd was established in 1994 as a manufacturer of Specials and has since grown and diversified into several areas of the pharmaceutical industry. It has gained a global reputation for the aseptic manufacture of complex and innovative investigational medicines for a wide range of pharmaceutical and biotechnology companies. It has also successfully launched two Licensed products and continues to develop more.
PRODUCTS/SERVICES
Our state-of-the-art facilities allow us to provide virtually any pharmaceutical dosage form, including non-sterile cytotoxic formulations, as Specials. Our highly skilled team of formulation pharmacists continue to develop and produce new formulations with >10,000 formulations currently available. We can provide aseptic fill/finish of small molecules, peptides, MABs and live biologics for clinical trials and we are world leading in aseptic thermo-stabilisation platforms, including spray drying. We manufacture Xaluprine® for the treatment of Acute Lymphoblastic Leukaemia (ALL) and Xromi® for the treatment of Sickle Cell Disease.